A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GSK Biologicals Candidate Pneumococcal Vaccine Without or With Adjuvant, Administered at 2 Different Concentrations, in Healthy Elderly Subjects.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Pneumococcal 11-valent vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary) ; Adjuvants
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics
- 05 Oct 2011 New trial record